DNA
Ginkgo Bioworks Holdings, Inc.
NYSE · Healthcare · Biotechnology · US
$6.95
+0.00%Leverage
- Debt / equity
- 0.96x
- Net debt / equity
- 0.76x
- Debt / assets
- 0.41x
- Debt / EBITDA
- -1.93x
- Net debt / EBITDA
- -1.53x
Liquidity & coverage
- Current ratio
- 4.57x
- Quick ratio
- 4.57x
- Cash ratio
- 4.15x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $259.8M
Cash & dividend
- FCF / debt
- -0.47x
- Cash flow / debt
- -0.42x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026